Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Poland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20131
20151
20163
20172
20181
20191
20206
20212
20222
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated7
Recruiting5
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)3
Amgen2
Applied Molecular Transport2
AstraZeneca2
Eli Lilly and Company2
Lakefront Biotherapeutics NV2
Protagonist Therapeutics, Inc.2
Spyre Therapeutics, Inc.2
Bristol-Myers Squibb1
EA Pharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases30
Colitis, Ulcerative20
Crohn Disease9
Colitis7
Gastrointestinal Diseases4
Digestive System Diseases3
Abdominal Pain2
Colonic Diseases2
Inflammation2
Intestinal Diseases2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.